MedTrace Logo

A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT04745676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-03-31

Study results available
· View outcomes & findings →

Summary

This is a pilot study to evaluate the usability and feasibility of a telehealth-delivered advance care planning intervention among 20 older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Conditions

Interventions

BEHAVIORAL

Telehealth

Telehealth ACP intervention advance care planning intervention

BEHAVIORAL

Control

For the control arm, no telehealth visit will be scheduled.

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Kah Poh Loh · Univ. of Rochester Wilmot Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-25
Primary Completion
2023-03-01
Completion
2023-07-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745676 on ClinicalTrials.gov